Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,504 | -212,184 | -151,653 | -89,332 | -34,085 |
| Depreciation Amortization | -980 | -8,238 | -6,695 | -5,043 | -2,507 |
| Accounts payable and accrued liabilities | 2,741 | 1,070 | -680 | -1,598 | -1,277 |
| Other Working Capital | -10,021 | 3,526 | -4,869 | -11,198 | -11,481 |
| Other Operating Activity | 9,528 | 35,433 | 26,804 | 17,877 | 7,974 |
| Operating Cash Flow | $-62,236 | $-180,393 | $-137,093 | $-89,294 | $-41,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -933 | -913 | -887 | -851 |
| Purchase Of Investment | -93,762 | -849,585 | -491,312 | -405,876 | -347,250 |
| Sale Of Investment | 152,069 | 456,219 | 320,819 | 185,819 | 75,468 |
| Investing Cash Flow | $58,307 | $-394,299 | $-171,406 | $-220,944 | $-272,633 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,697 | 473,407 | 256,153 | 244,856 | 244,251 |
| Other Financing Activity | 0 | 0 | 578 | 287 | 0 |
| Financing Cash Flow | $1,697 | $473,407 | $256,731 | $245,143 | $244,251 |
| Beginning Cash Position | 91,387 | 192,672 | 192,672 | 192,672 | 192,672 |
| End Cash Position | 89,155 | 91,387 | 140,904 | 127,577 | 122,914 |
| Net Cash Flow | $-2,232 | $-101,285 | $-51,768 | $-65,095 | $-69,758 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,236 | -180,393 | -137,093 | -89,294 | -41,376 |
| Capital Expenditure | N/A | -933 | -913 | -887 | -851 |
| Free Cash Flow | -62,236 | -181,326 | -138,006 | -90,181 | -42,227 |